A woman holds an informational pamphlet on lenacapavir, new HIV prevention drug, in Harare, Zimbabwe
Kenya began administering the first doses of lenacapavir—a groundbreaking twice-yearly HIV prevention injection—in a Nairobi slum on Thursday, offering new hope in the country’s fight against the virus.
“Today is a moment of hope for thousands of Kenyan families,” Health Minister Aden Duale said during the launch in Kawangware.
The drug, which reduces HIV transmission risk by over 99.9%, will be provided free of charge.
Hope and relief
Samson Mutua, 27, became the first recipient. Peace Lawrence, a 23-year-old sex worker, called the injection “a relief,” saying she often forgot daily PrEP pills.
“Having sex with multiple partners always leaves me in fear,” she told AFP.
Community health worker Carol Njomo explained that eligibility requires being HIV-negative, over 15, and at high risk.
Cushioning against aid cuts
Kenya received 21,000 doses through Gilead Sciences and the Global Fund.
The rollout comes as African countries grapple with U.S. aid cuts affecting HIV programs across the continent.
𝐊𝐞𝐧𝐲𝐚 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬 𝐋𝐨𝐧𝐠-𝐀𝐜𝐭𝐢𝐧𝐠 𝐇𝐈𝐕 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐈𝐧𝐣𝐞𝐜𝐭𝐢𝐨𝐧
Kenya has officially launched Lenacapavir, a groundbreaking long-acting injectable for HIV prevention, in a major step to curb new infections and strengthen the national HIV… pic.twitter.com/Zf2iEEkgII
— Ministry of Health (@MOH_Kenya) February 26, 2026
